From left: Accenture Global Managing Director Salwa Rafee, Health-ISAC Chief Security Officer Errol Weiss, Health Sector Coordinating Council Cybersecurity Working Group Executive Director Greg Garcia, and Armis CTO and Co-Founder Nadir Izrael discuss how cyberthreats are evolving.
Medical…
Source: healthtechmagazine.net – Read more
Novartis Nabs FDA Approval for First-of-Its-Kind Drug for Chronic Hives
Novartis drug Rhapsido is now approved as a second-line treatment for chronic spontaneous urticaria, a rare inflammatory skin disease. Additional clinical trials are ongoing to
